Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000231118 | SCV000286050 | benign | Rhabdoid tumor predisposition syndrome 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000564684 | SCV000663907 | likely benign | Hereditary cancer-predisposing syndrome | 2015-05-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000608789 | SCV000732697 | likely benign | not specified | 2017-06-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001808618 | SCV002057089 | benign | Intellectual disability, autosomal dominant 16 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000564684 | SCV002532911 | benign | Hereditary cancer-predisposing syndrome | 2021-03-26 | criteria provided, single submitter | curation | |
Ce |
RCV003407773 | SCV004137787 | benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | SMARCA4: BP4, BP7, BS1, BS2 |
Prevention |
RCV003937890 | SCV004752755 | benign | SMARCA4-related disorder | 2020-02-21 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |